The report is titled ‘Implantable Pulse Generator Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the implantable pulse generator market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Implantable pulse generator market is expected to grow at a significant rate in the near future.
The global implantable pulse generator market in 2020 is estimated for more than US$ 2.5 Bn and expected to reach a value of US$ 5.3 Bn by 2028 with a significant CAGR of 9.9%.
The implantable pulse generator (IPG) is battery-operated, micro-electronic medical equipment, embedded in the patient’s body, which transmits electric stimulation to the nervous system with a focus on triggering or arousing different nerve impulses in the body.
The implantable pulse generator is one of the most assuring and up-and-coming technologies which carries the potential to treat various medical conditions like reducing back pain, stress, hypertension, obesity, and help cure diabetes with an eye to hold back or end the dosage of insulin that needs to be taken on a daily basis.
Owing to this, the implantable pulse generators observe enormous demand in the healthcare industry across the globe. In addition to that, the implantable pulse generators also serve their utility in situations where the medications are either showing some adverse effects or are fully ineffective.
Attributable to such factors, the implantable pulse generators are preferred over the other medications, which further fuels the growth of the global implantable pulse generator market in the forthcoming years.
Basically, the implantable pulse generators are designed and computed with the intention to offer electrical stimuli to the nervous systems and are crucial for neuro-modulation. The constant and rapid advancement of technologies in the healthcare industry over the past few decades is another major factor that has fueled the growth in the demand for enhanced medical devices and treatments which in turn has elevated the growth of the implantable pulse generator market.
Along with that, the dynamic life patterns of the population in the present-day world is resulting in a raised number of chronic ailments spread across the world, which is also positively fueling the growth of the global implantable pulse generator market in the forthcoming years.
Apart from that, neuromodulation is one of the novels and advanced medical methods and has a considerable amount of successful trials and turned out more effective and safe in comparison to the conventional methods, which is also acting as one of the key factors that is estimated to give a positive push to the growth of the implantable pulse generator market during the forecast timeframe.
Although, the need to replace the implantable pulse generator or change batteries, which needs surgery is a factor that may restrict the growth of the implantable pulse generator market in the coming years.
The implantable pulse generator market is segmented on the basis of product type, application, end-user, and region.
On the basis of product type, the global implantable pulse generator market is segmented into
• Implantable Cardiac Pacemakers
• Implantable Defibrillators
• Cochlear Implants
• Implantable Nerve Stimulators (FES)
• Limb Function Stimulation
• Bladder Stimulators
• Sphincter Stimulators
• Diaphragm Stimulators
• Analgesia
• Implantable Infusion Pumps
• Implantable Active Monitoring Devices
On the basis of application, the market is segmented into
• Neurovascular Diseases
• Cardiovascular Diseases
• Orthopedic
On the basis of End User, the market is segmented into
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Clinics
On the basis of Region, the global implantable pulse generator market is segmented into
• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
• Europe (U.K., Germany, Italy, France, Spain, Russia, Poland, BENELUX, NORDIC)
• Asia Pacific (China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia)
• Middle East (GCC Countries, Israel, Oman, Rest of Middle East)
• Africa (South Africa, Egypt, North Africa, Rest of Africa)
Some of the key participating players in the implantable pulse generator market are Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Synapse Biomedical, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Cyberonics, Inc., and BioControl Medical.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Implantable Pulse Generator market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth include (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Implantable Pulse Generator
• Advantages of Implantable Pulse Generator
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.
A mix of the top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.
1. Global Implantable Pulse Generator Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Implantable Pulse Generator Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Implantable Pulse Generator Market Snapshot
2.4. Global Implantable Pulse Generator Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Implantable Pulse Generator Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Implantable Pulse Generator Market, By Product Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Product Type
3.1.2. BPS Analysis, By Product Type
3.2. Market Revenue (US$Mn) Forecast, By Product Type
3.2.1. Implantable Cardiac Pacemakers
3.2.2. Implantable Defibrillators
3.2.3. Cochlear Implants
3.2.4. Implantable Nerve Stimulators (FES)
3.2.4.1. Limb Function Stimulation
3.2.4.2. Bladder Stimulators
3.2.4.3. Sphincter Stimulators
3.2.4.4. Diaphragm Stimulators
3.2.4.5. Analgesia
3.2.5. Implantable Infusion Pumps
3.2.6. Implantable Active Monitoring Devices
3.3. Global Implantable Pulse Generator Market Attractiveness Index, By Product Type
4. Global Implantable Pulse Generator Market, By Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Application
4.1.2. BPS Analysis, By Application
4.2. Market Revenue (US$Mn) Forecast, By Application
4.2.1. Neurovascular Diseases
4.2.2. Cardiovascular Diseases
4.2.3. Orthopedic
4.3. Global Implantable Pulse Generator Market Attractiveness Index, By Application
5. Global Implantable Pulse Generator Market, By End User
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End User
5.1.2. BPS Analysis, By End User
5.2. Market Revenue (US$Mn) Forecast, By End User
5.2.1. Hospitals
5.2.2. Ambulatory Surgical Centers
5.2.3. Home Care Settings
5.2.4. Clinics
5.3. Global Implantable Pulse Generator Market Attractiveness Index, By End User
6. Global Implantable Pulse Generator Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Implantable Pulse Generator Market Attractiveness Index, By Region
7. North America Implantable Pulse Generator Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Implantable Pulse Generator Market
7.2.2. Canada Implantable Pulse Generator Market
7.3. North America Implantable Pulse Generator Market, By Product Type
7.3.1. Implantable Cardiac Pacemakers
7.3.2. Implantable Defibrillators
7.3.3. Cochlear Implants
7.3.4. Implantable Nerve Stimulators (FES)
7.3.4.1. Limb Function Stimulation
7.3.4.2. Bladder Stimulators
7.3.4.3. Sphincter Stimulators
7.3.4.4. Diaphragm Stimulators
7.3.4.5. Analgesia
7.3.5. Implantable Infusion Pumps
7.3.6. Implantable Active Monitoring Devices
7.4. North America Implantable Pulse Generator Market, By Application
7.4.1. Neurovascular Diseases
7.4.2. Cardiovascular Diseases
7.4.3. Orthopedic
7.5. North America Implantable Pulse Generator Market, By End User
7.5.1. Hospitals
7.5.2. Ambulatory Surgical Centers
7.5.3. Home Care Settings
7.5.4. Clinics
7.6. North America Implantable Pulse Generator Market Attractiveness Index
7.6.1. By Country
7.6.2. By Product Type
7.6.3. By Application
7.6.4. By End User
8. Latin America Implantable Pulse Generator Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Implantable Pulse Generator Market
8.2.2. Mexico Implantable Pulse Generator Market
8.2.3. Argentina Implantable Pulse Generator Market
8.2.4. Rest of Latin America Implantable Pulse Generator Market
8.3. Latin America Implantable Pulse Generator Market, By Product Type
8.3.1. Implantable Cardiac Pacemakers
8.3.2. Implantable Defibrillators
8.3.3. Cochlear Implants
8.3.4. Implantable Nerve Stimulators (FES)
8.3.4.1. Limb Function Stimulation
8.3.4.2. Bladder Stimulators
8.3.4.3. Sphincter Stimulators
8.3.4.4. Diaphragm Stimulators
8.3.4.5. Analgesia
8.3.5. Implantable Infusion Pumps
8.3.6. Implantable Active Monitoring Devices
8.4. Latin America Implantable Pulse Generator Market, By Application
8.4.1. Neurovascular Diseases
8.4.2. Cardiovascular Diseases
8.4.3. Orthopedic
8.5. Latin America Implantable Pulse Generator Market, By End User
8.5.1. Hospitals
8.5.2. Ambulatory Surgical Centers
8.5.3. Home Care Settings
8.5.4. Clinics
8.6. Latin America Implantable Pulse Generator Market Attractiveness Index
8.6.1. By Country
8.6.2. By Product Type
8.6.3. By Application
8.6.4. By End User
9. Europe Implantable Pulse Generator Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Implantable Pulse Generator Market
9.2.2. Germany Implantable Pulse Generator Market
9.2.3. Italy Implantable Pulse Generator Market
9.2.4. France Implantable Pulse Generator Market
9.2.5. Spain Implantable Pulse Generator Market
9.2.6. Russia Implantable Pulse Generator Market
9.2.7. Poland Implantable Pulse Generator Market
9.2.8. BENELUX Implantable Pulse Generator Market
9.2.9. NORDIC Implantable Pulse Generator Market
9.2.10. Rest of Europe Implantable Pulse Generator Market
9.3. Europe Implantable Pulse Generator Market, By Product Type
9.3.1. Implantable Cardiac Pacemakers
9.3.2. Implantable Defibrillators
9.3.3. Cochlear Implants
9.3.4. Implantable Nerve Stimulators (FES)
9.3.4.1. Limb Function Stimulation
9.3.4.2. Bladder Stimulators
9.3.4.3. Sphincter Stimulators
9.3.4.4. Diaphragm Stimulators
9.3.4.5. Analgesia
9.3.5. Implantable Infusion Pumps
9.3.6. Implantable Active Monitoring Devices
9.4. Europe Implantable Pulse Generator Market, By Application
9.4.1. Neurovascular Diseases
9.4.2. Cardiovascular Diseases
9.4.3. Orthopedic
9.5. Europe Implantable Pulse Generator Market, By End User
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Home Care Settings
9.5.4. Clinics
9.6. Europe Implantable Pulse Generator Market Attractiveness Index
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Application
9.6.4. By End User
10. Asia Pacific Implantable Pulse Generator Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Implantable Pulse Generator Market
10.2.2. India Implantable Pulse Generator Market
10.2.3. Japan Implantable Pulse Generator Market
10.2.4. Australia and New Zealand Implantable Pulse Generator Market
10.2.5. South Korea Implantable Pulse Generator Market
10.2.6. ASEAN Implantable Pulse Generator Market
10.2.7. Rest of Asia Pacific Implantable Pulse Generator Market
10.3. Asia Pacific Implantable Pulse Generator Market, By Product Type
10.3.1. Implantable Cardiac Pacemakers
10.3.2. Implantable Defibrillators
10.3.3. Cochlear Implants
10.3.4. Implantable Nerve Stimulators (FES)
10.3.4.1. Limb Function Stimulation
10.3.4.2. Bladder Stimulators
10.3.4.3. Sphincter Stimulators
10.3.4.4. Diaphragm Stimulators
10.3.4.5. Analgesia
10.3.5. Implantable Infusion Pumps
10.3.6. Implantable Active Monitoring Devices
10.4. Asia Pacific Implantable Pulse Generator Market, By Application
10.4.1. Neurovascular Diseases
10.4.2. Cardiovascular Diseases
10.4.3. Orthopedic
10.5. Asia Pacific Implantable Pulse Generator Market, By End User
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Home Care Settings
10.5.4. Clinics
10.6. Asia Pacific Implantable Pulse Generator Market Attractiveness Index
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Application
10.6.4. By End User
11. Middle East Implantable Pulse Generator Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Implantable Pulse Generator Market
11.2.2. Israel Implantable Pulse Generator Market
11.2.3. Oman Implantable Pulse Generator Market
11.2.4. Rest of Middle East Implantable Pulse Generator Market
11.3. Middle East Implantable Pulse Generator Market, By Product Type
11.3.1. Implantable Cardiac Pacemakers
11.3.2. Implantable Defibrillators
11.3.3. Cochlear Implants
11.3.4. Implantable Nerve Stimulators (FES)
11.3.4.1. Limb Function Stimulation
11.3.4.2. Bladder Stimulators
11.3.4.3. Sphincter Stimulators
11.3.4.4. Diaphragm Stimulators
11.3.4.5. Analgesia
11.3.5. Implantable Infusion Pumps
11.3.6. Implantable Active Monitoring Devices
11.4. Middle East Implantable Pulse Generator Market, By Application
11.4.1. Neurovascular Diseases
11.4.2. Cardiovascular Diseases
11.4.3. Orthopedic
11.5. Middle East Implantable Pulse Generator Market, By End User
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Home Care Settings
11.5.4. Clinics
11.6. Middle East Implantable Pulse Generator Market Attractiveness Index
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Application
11.6.4. By End User
12. Africa Implantable Pulse Generator Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Implantable Pulse Generator Market
12.2.2. Egypt Implantable Pulse Generator Market
12.2.3. North Africa Implantable Pulse Generator Market
12.2.4. Rest of Africa Implantable Pulse Generator Market
12.3. Africa Implantable Pulse Generator Market, By Product Type
12.3.1. Implantable Cardiac Pacemakers
12.3.2. Implantable Defibrillators
12.3.3. Cochlear Implants
12.3.4. Implantable Nerve Stimulators (FES)
12.3.4.1. Limb Function Stimulation
12.3.4.2. Bladder Stimulators
12.3.4.3. Sphincter Stimulators
12.3.4.4. Diaphragm Stimulators
12.3.4.5. Analgesia
12.3.5. Implantable Infusion Pumps
12.3.6. Implantable Active Monitoring Devices
12.4. Africa Implantable Pulse Generator Market, By Application
12.4.1. Neurovascular Diseases
12.4.2. Cardiovascular Diseases
12.4.3. Orthopedic
12.5. Africa Implantable Pulse Generator Market, By End User
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Home Care Settings
12.5.4. Clinics
12.6. Africa Implantable Pulse Generator Market Attractiveness Index
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Application
12.6.4. By End User
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Boston Scientific Corporation
14.3.3. St. Jude Medical, Inc.
14.3.4. Synapse Biomedical, Inc.
14.3.5. Nevro Corporation
14.3.6. Neurosigma, Inc.
14.3.7. Neuropace, Inc.
14.3.8. Cyberonics, Inc.
14.3.9. BioControl Medical
14.3.10. Others
15. Acronyms